A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours
Status:
Recruiting
Trial end date:
2024-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to allow RC88 treatment of patients with advanced solid tumours
to assess the safety and tolerability of clinical pharmacology studies